相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名:
MLO-Y4
- 库存:
1x10^6/瓶/支
- 供应商:
上海酶研
- 肿瘤类型:
详询
- 细胞类型:
小鼠骨样细胞
- ATCC Number:
详询
- 品系:
MLO-Y4
- 组织来源:
小鼠骨样细胞
- 相关疾病:
MLO-Y4
- 物种来源:
哺乳动物
- 免疫类型:
详询
- 细胞形态:
贴壁/悬浮
- 是否是肿瘤细胞:
详询
- 器官来源:
小鼠骨样细胞
- 运输方式:
顺丰快递
- 年限:
5年
- 生长状态:
生长良好
MLO-Y4 /MLO-Y4 细胞系/MLO-Y4 细胞株/MLO-Y4 小鼠骨样细胞
Cell line name MLO-Y4
Synonyms MLOY4; Murine Long bone Osteocyte-Y4
Accession CVCL_M098
Resource Identification Initiative To cite this cell line use: MLO-Y4 (RRID:CVCL_M098)
Comments Group: Patented cell line.
Group: Space-flown cell line (cellonaut).
Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12161.
Characteristics: Useful to study effects of fluid flow and substrate stretching on activation of osteocyte-specific signaling pathways (Kerafast=EKC002).
Doubling time: 15.8 hours (CelloPub=CLPUB00625).
Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; SV40 large T antigen.
Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
Derived from site: In situ; Bone, long bone; UBERON=UBERON_0002495.
Cell type: Osteocyte; CL=CL_0000137.
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: (C57BL/6J x BALB/cJ) F2 Bgla promoter T-Ag transgenic.
Hierarchy Children:
CVCL_C8UU (MLO-Y4-Luc) CVCL_E0Z7 (Ubigene MLO-Y4 Tnfsf11 KO)
Sex of cell Sex unspecified
Age at sampling 14D
Category Transformed cell line
STR profile Source(s): Ubigene=YC-C037
Markers:
Mouse STR 4-2 20.3,21.3
Mouse STR 5-5 14
Mouse STR 6-4 18
Mouse STR 6-7 17
Mouse STR 12-1 17
Mouse STR 15-3 22.3
Mouse STR 18-3 17,18
Mouse STR X-1 25
Run an STR similarity search on this cell line
Publications
PubMed=9421234; DOI=10.1359/jbmr.1997.12.12.2014
Kato Y., Windle J.J., Koop B.A., Mundy G.R., Bonewald L.F.
Establishment of an osteocyte-like cell line, MLO-Y4.
J. Bone Miner. Res. 12:2014-2023(1997)
PubMed=10084404; DOI=10.1007/s007740050066
Bonewald L.F.
Establishment and characterization of an osteocyte-like cell line, MLO-Y4.
J. Bone Miner. Metab. 17:61-65(1999)
Patent=US6358737
Bonewald L.F., Kato Y.
Osteocyte cell lines.
Patent number US6358737, 19-Mar-2002
PubMed=12412815; DOI=10.1359/jbmr.2002.17.11.2068
Zhao S., Zhang Y.K., Harris S., Ahuja S.S., Bonewald L.F.
MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
J. Bone Miner. Res. 17:2068-2079(2002)
CLPUB00625
Lau P., Hellweg C.E., Kirchner S., Arenz A., Baumstark-Khan C., Horneck G.
Induction of DNA-strand breaks after X-irradiation in murine bone cells of various differentiation capacities.
(In conference) Abstracts of the 35th COSPAR scientific assembly; pp.1960-1960; Committee on Space Research; Paris; France (2004)
PubMed=16738320; DOI=10.1128/mcb.02120-05; PMCID=PMC1489126
Zhang K.-Q., Barragan-Adjemian C., Ye L., Kotha S., Dallas M., Lu Y.-B., Zhao S.-J., Harris M., Harris S.E., Feng J.Q., Bonewald L.F.
E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation.
Mol. Cell. Biol. 26:4539-4552(2006)
PubMed=22130923; DOI=10.1007/978-1-61779-415-5_6
Rosser J., Bonewald L.F.
Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5.
Methods Mol. Biol. 816:67-81(2012)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验*发表【中文论文】请标注:由上海酶研生物科技有限公司提供;
*发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.
Studying Osteocyte Function Using the Cell Lines MLO-Y4 and MLO-A5
We describe the culture and use of MLO-Y4 cells in studies of gene expression, response to fluid flow, and dendrite growth. We also describe how to use the MLO-A5 cells as a model of osteoblast to osteocyte �differentiation and how to study
三句话读懂一篇 CNS:新疗法助力治疗女性不育;能负载活细胞的冷冻微针治疗技术;发现治疗心肌梗死新靶标,...
夏日好时光,本周学术君继续带你遨游学术之海,探寻科学的奥秘。 1. Nature Biomedical Engineering:首创冷冻微针治疗技术 细胞治疗,是一种能够将活细胞传递至体内发挥治疗效果的新型技术。 2021 年 5 月 3 日,香港城市大学徐臣杰教授研究团队在 Nature Biomedical Engineering 杂志上发表研究论文 Cryomicroneedles for Transdermal Cell Delivery。该工作首次创建能够负载活细胞的冷冻微针技术
真爱满行囊 我最近在体外细胞做的关于gsk3-beta功能问题,发现药物处理以后,gsk-3-beta的总表达量下调,如果是这样的话 1、我是否能够得出gsk-3-beta的活性下调的结论? 2、是否还有必要做非活性形式的表达量?我的理解是,基础状态下,gsk-3beta维持的是低活性状态,如果总量都下调了,那应该能够得出活性降低的结论了吧? 3、另外,在这种情况下我是否有必要去做gsk-3-beta的216位点的活性形式的表达
技术资料






![【ATCC来源】EL4细胞、EL4细胞、EL4[小鼠淋巴瘤细胞]](https://img1.dxycdn.com/2021/0721/054/1466071650690953943-14.jpg!wh200)
